Grants and Contributions:
Title:
Innovation Assistance Program
Agreement Number:
952422
Agreement Value:
$0.00
Agreement Date:
Apr 1, 2020 - Apr 2, 2020
Description:
The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.
Organization:
National Research Council Canada
Expected Results:
The purpose of IAP is to provide support to assist innovative, early-stage companies that are unable to access other COVID-19 business supports.
Location:
Laval, Quebec, CA H7G 3Z8
Reference Number:
172-2020-2021-Q2-952422
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
742858285
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -83 days. The total amended value is -48,528 dollars.
Amendment Date
Mar 15, 2021
Recipient's Operating Name:
Pixi Médical
Recipient's Legal Name:
9378-5913 Quebec Inc.
Federal Riding Name:
Vimy
Federal Riding Number:
24078
Program:
Industrial Research Assistance Program – Innovation Assistance Program
Program Purpose:
The purpose of IAP is to provide support to assist innovative, early-stage companies that are unable to access other COVID-19 business supports.
Coverage:
IRAP IAP Contributions provide wage support to early-stage, innovative firms and help position them for future growth and wealth creation for Canada through technological innovation.
Amendments: